Moderna & Merck Announce Promising Results From mRNA Cancer Vaccine For Melanoma

Ask an Expert

Moderna & Merck Announce Promising Results From mRNA Cancer Vaccine For Melanoma

← All Community

For the first time ever reported in a phase three trial, we are seeing promising results for a personalized mRNA vaccine treatment from Moderna and Merck in melanoma patients treating remaining cells after surgery to remove the primary site.

Share this

Keep Exploring

Ask an Expert

Managing Treatment Side Effects at HomePlaceholder

Ask an Expert

How Do I Know If a Clinical Trial Is Right for Me?Placeholder

Ask an Expert

What Questions Should I Bring to My First Oncology Appointment?Placeholder

Join us at The Cancer Project

Get weekly stories, research updates, and ways to get involved.

© 2026 The Cancer Project